Bioengineering virus-like particles as vaccines (Q38172045)

30 August 2017

Bioengineering virus-like particles as vaccines (English)

1 reference

30 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Natalie K Connors

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Frank Sainsbury

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

6

Anton P J Middelberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Yap P Chuan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Nani Wibowo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

17 December 2013

1 reference

Biotechnology and Bioengineering

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

425-440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles

11 June 2020

cites work

1 reference

Cryo-electron microscopy of viruses

21 January 2018

1 reference

Vaccine adjuvants revisited

21 January 2018

1 reference

Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines

21 January 2018

1 reference

Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle.

21 January 2018

1 reference

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles

21 January 2018

1 reference

Production and purification of human papillomavirus type 33 L1 virus-like particles from Spodoptera frugiperda 9 cells using two-step column chromatography

21 January 2018

1 reference

Packaging of up to 240 subunits of a 17 kDa nuclease into the interior of recombinant hepatitis B virus capsids.

21 January 2018

1 reference

Hepatitis E vaccine debuts.

21 January 2018

1 reference

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen.

21 January 2018

1 reference

Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein

21 January 2018

1 reference

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

21 January 2018

1 reference

Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.

21 January 2018

1 reference

Efficient disulfide bond formation in virus-like particles

21 January 2018

1 reference

Escherichia coli-based cell-free synthesis of virus-like particles.

21 January 2018

1 reference

Developments in virus-like particle-based vaccines for HIV.

21 January 2018

1 reference

Stability and assembly in vitro of bacteriophage PP7 virus-like particles

21 January 2018

1 reference

VIPERdb2: an enhanced and web API enabled relational database for structural virology

21 January 2018

1 reference

Separation and quantification of double- and triple-layered rotavirus-like particles by CZE.

21 January 2018

1 reference

Virus-like particles: flexible platforms for vaccine development

21 January 2018

1 reference

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

21 January 2018

1 reference

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles

21 January 2018

1 reference

Quantitative analysis of virus-like particle size and distribution by field-flow fractionation.

21 January 2018

1 reference

Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres.

21 January 2018

1 reference

Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine

21 January 2018

1 reference

Expression, purification and characterization of enterovirus-71 virus-like particles

21 January 2018

1 reference

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

21 January 2018

1 reference

Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering

21 January 2018

1 reference

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

21 January 2018

1 reference

Virus-like particles as a rotavirus subunit vaccine.

21 January 2018

1 reference

Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae

21 January 2018

1 reference

Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.

21 January 2018

1 reference

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

21 January 2018

1 reference

AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity

21 January 2018

1 reference

Modeling the competition between aggregation and self-assembly during virus-like particle processing.

21 January 2018

1 reference

Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor

21 January 2018

1 reference

Insect cells as a production platform of complex virus-like particles

21 January 2018

1 reference

Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine

21 January 2018

1 reference

RNA-directed packaging of enzymes within virus-like particles

21 January 2018

1 reference

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

21 January 2018

1 reference

Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris

21 January 2018

1 reference

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge

21 January 2018

1 reference

A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets

21 January 2018

1 reference

Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines

21 January 2018

1 reference

A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection

21 January 2018

1 reference

Osmolyte-mediated encapsulation of proteins inside MS2 viral capsids

21 January 2018

1 reference

Coupling of antibodies via protein Z on modified polyoma virus-like particles

21 January 2018

1 reference

Defying malaria: Arming T cells to halt malaria.

21 January 2018

1 reference

The atomic structure of the bluetongue virus core

21 January 2018

1 reference

Structure of correctly self-assembled bluetongue virus-like particles

21 January 2018

1 reference

Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines

21 January 2018

1 reference

Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles

21 January 2018

1 reference

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

21 January 2018

1 reference

Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the minor capsid proteins VP2/3.

21 January 2018

1 reference

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

21 January 2018

1 reference

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

The many roles of computation in drug discovery

21 January 2018

1 reference

A molecular dynamics study of loop fluctuation in human papillomavirus type 16 virus-like particles: a possible indicator of immunogenicity

21 January 2018

1 reference

Multiscale simulation of microbe structure and dynamics

21 January 2018

1 reference

Protein delivery using engineered virus-like particles

21 January 2018

1 reference

Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches

21 January 2018

1 reference

Virus-like particles as universal influenza vaccines

21 January 2018

1 reference

A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein.

21 January 2018

1 reference

SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier

21 January 2018

1 reference

Design of hybrid lipid/retroviral-like particle gene delivery vectors

21 January 2018

1 reference

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

Physical stabilization of Norwalk virus-like particles

21 January 2018

1 reference

H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers

21 January 2018

1 reference

Computer-aided antibody design

21 January 2018

1 reference

Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development

21 January 2018

1 reference

Atomic force microscopy in imaging of viruses and virus-infected cells

21 January 2018

1 reference

In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes

21 January 2018

1 reference

Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected].

21 January 2018

1 reference

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses

21 January 2018

1 reference

Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.

21 January 2018

1 reference

Microbial production of virus-like particle vaccine protein at gram-per-litre levels.

21 January 2018

1 reference

Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution

21 January 2018

1 reference

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.

21 January 2018

1 reference

Encapsulation of DNA and non-viral protein changes the structure of murine polyomavirus virus-like particles

21 January 2018

1 reference

Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering.

21 January 2018

1 reference

Affinity purification of viral protein having heterogeneous quaternary structure: modeling the impact of soluble aggregates on chromatographic performance.

21 January 2018

1 reference

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

21 January 2018

1 reference

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

21 January 2018

1 reference

Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media

21 January 2018

1 reference

Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs).

21 January 2018

1 reference

Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

21 January 2018

1 reference

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

21 January 2018

1 reference

Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins

21 January 2018

1 reference

Recombinant-expressed virus-like particle pseudotypes as an approach to vaccine development

21 January 2018

1 reference

Effective chikungunya virus-like particle vaccine produced in insect cells

21 January 2018

1 reference

Viral structural transition mechanisms revealed by multiscale molecular dynamics/order parameter extrapolation simulation

21 January 2018

1 reference

A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.

21 January 2018

1 reference

Controlled encapsulation of multiple proteins in virus capsids.

21 January 2018

1 reference

Virus-like particle formulation optimization by miniaturized high-throughput screening.

21 January 2018

1 reference

Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine

21 January 2018

1 reference

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres

21 January 2018

1 reference

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology

21 January 2018

1 reference

Virus-like particles as immunogens

21 January 2018

1 reference

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

21 January 2018

1 reference

Low pH-triggered model drug molecule release from virus-like particles

21 January 2018

1 reference

Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22.

21 January 2018

1 reference

Nanosystem self-assembly pathways discovered via all-atom multiscale analysis

21 January 2018

1 reference

Towards the preparative and large-scale precision manufacture of virus-like particles

21 January 2018

1 reference

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation

21 January 2018

1 reference

Quantitative characterization of virus-like particles by asymmetrical flow field flow fractionation, electrospray differential mobility analysis, and transmission electron microscopy

21 January 2018

1 reference

Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles

21 January 2018

1 reference

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens

21 January 2018

1 reference

Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design

21 January 2018

1 reference

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen

21 January 2018

1 reference

X-ray crystallographic structure of the Norwalk virus capsid

21 January 2018

1 reference

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes

21 January 2018

1 reference

Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures

21 January 2018

1 reference

Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.

21 January 2018

1 reference

Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus

21 January 2018

1 reference

Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS).

21 January 2018

1 reference

Investigation of a predicted N-terminal amphipathic α-helix using atomistic molecular dynamics simulation of a complete prototype poliovirus virion

21 January 2018

1 reference

Virus-like particles in vaccine development.

21 January 2018

1 reference

On the effect of thermodynamic equilibrium on the assembly efficiency of complex multi-layered virus-like particles (VLP): the case of rotavirus VLP.

21 January 2018

1 reference

Hepatitis B core-based virus-like particles to present heterologous epitopes

21 January 2018

1 reference

Peptide-controlled access to the interior surface of empty virus nanoparticles.

21 January 2018

1 reference

Self-assembly of purified polyomavirus capsid protein VP1.

21 January 2018

1 reference

Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants

21 January 2018

1 reference

Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity

21 January 2018

1 reference

Mechanism of assembly of recombinant murine polyomavirus-like particles

21 January 2018

1 reference

A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

21 January 2018

1 reference

Virus-like particles produced in plants as potential vaccines

21 January 2018

1 reference

Biological gene delivery vehicles: beyond viral vectors

21 January 2018

1 reference

Stabilization of human papillomavirus virus-like particles by non-ionic surfactants

21 January 2018

1 reference

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins

21 January 2018

1 reference

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

21 January 2018

1 reference

Chemical introduction of reactive thiols into a viral nanoscaffold: a method that avoids virus aggregation

21 January 2018

1 reference

Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor

21 January 2018

1 reference

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response

21 January 2018

1 reference

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

21 January 2018

1 reference

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

21 January 2018

1 reference

Expression of Chikungunya Virus-like Particles

21 January 2018

1 reference

Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.

21 January 2018

1 reference

Protein transduction from retroviral Gag precursors

21 January 2018

1 reference

Vaccine potential of Nipah virus-like particles

21 January 2018

1 reference

Advances in virus-like particle vaccines for filoviruses

21 January 2018

1 reference

Use of hepadnavirus core proteins as vaccine platforms

21 January 2018

1 reference

Cell-specific delivery of bacteriophage-encapsidated ricin A chain

21 January 2018

1 reference

Capsomer vaccines protect mice from vaginal challenge with human papillomavirus

21 January 2018

1 reference

The crystal structure of the human hepatitis B virus capsid

21 January 2018

1 reference

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

21 January 2018

1 reference

Construction and characterization of virus-like particles: a review

21 January 2018

1 reference

HPV6b virus like particles are potent immunogens without adjuvant in man.

21 January 2018

1 reference

Molecular energetics in the capsomere of virus-like particle revealed by molecular dynamics simulations

21 January 2018

1 reference

In vitro assembly of cowpea chlorotic mottle virus from coat protein expressed in Escherichia coli and in vitro-transcribed viral cDNA.

21 January 2018

1 reference

Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles

21 January 2018

1 reference

Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity

21 January 2018

1 reference

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

21 January 2018

1 reference

Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris

21 January 2018

1 reference

Modular engineering of a microbially-produced viral capsomere vaccine for influenza

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIT.25159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24347238%20AND%20SRC:MED&resulttype=core&format=json

release_7rwuemfyizblvd3iu4mvum7yie

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7rwuemfyizblvd3iu4mvum7yie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference